These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29444253)

  • 21. Ultradeep sequencing in the therapeutic management of HIV-1 infection at treatment initiation.
    Todesco E; Mercier-Darty M; Jung M; Bottero J; Boyd A; Marcelin AG; Calvez V; Morand-Joubert L
    J Antimicrob Chemother; 2015; 70(6):1919-20. PubMed ID: 25637517
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of GS Junior and MiSeq next-generation sequencing technologies as an alternative to Trugene population sequencing in the clinical HIV laboratory.
    Ram D; Leshkowitz D; Gonzalez D; Forer R; Levy I; Chowers M; Lorber M; Hindiyeh M; Mendelson E; Mor O
    J Virol Methods; 2015 Feb; 212():12-6. PubMed ID: 25445792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a cost-effective assay for genotyping of HIV-1 non-B subtype for drug resistance.
    Ammaranond P; Sanguansittianant S; Raju PA; Cunningham P; Horthongkham N
    J Virol Methods; 2014 Apr; 199():102-7. PubMed ID: 24462843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel next generation sequencing assay as an alternative to currently available methods for hepatitis C virus genotyping.
    Dirani G; Paesini E; Mascetra E; Farabegoli P; Dalmo B; Bartolini B; Garbuglia AR; Capobianchi MR; Sambri V
    J Virol Methods; 2018 Jan; 251():88-91. PubMed ID: 29045810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasensitive single-genome sequencing: accurate, targeted, next generation sequencing of HIV-1 RNA.
    Boltz VF; Rausch J; Shao W; Hattori J; Luke B; Maldarelli F; Mellors JW; Kearney MF; Coffin JM
    Retrovirology; 2016 Dec; 13(1):87. PubMed ID: 27998286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Next-generation sequencing of dried blood spot specimens: a novel approach to HIV drug-resistance surveillance.
    Ji H; Li Y; Graham M; Liang BB; Pilon R; Tyson S; Peters G; Tyler S; Merks H; Bertagnolio S; Soto-Ramirez L; Sandstrom P; Brooks J
    Antivir Ther; 2011; 16(6):871-8. PubMed ID: 21900719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amino Acid Prevalence of HIV-1
    Tzou PL; Rhee SY; Shafer RW
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):924-929. PubMed ID: 31317771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 genotypic drug resistance testing: digging deep, reaching wide?
    Van Laethem K; Theys K; Vandamme AM
    Curr Opin Virol; 2015 Oct; 14():16-23. PubMed ID: 26114581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of Next-Generation Sequencing for Hepatitis B Virus Resistance Testing and Genotyping in a Clinical Microbiology Laboratory.
    Lowe CF; Merrick L; Harrigan PR; Mazzulli T; Sherlock CH; Ritchie G
    J Clin Microbiol; 2016 Jan; 54(1):127-33. PubMed ID: 26537448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Aspects of the Virus Life Cycle and Clinical Utility of Next Generation Sequencing based HIV-1 Resistance Testing in the Genomic, the Proviral, and the Viral Reservoir of Peripheral Blood Mononuclear Cells.
    Pröll J; Paar C; Taylor N; Skocic M; Freystetter A; Blaimschein A; Mayr R; Niklas N; Atzmüller S; Raml E; Wechselberger C
    Curr HIV Res; 2022; 20(3):213-221. PubMed ID: 35331114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.
    Nanfack AJ; Redd AD; Bimela JS; Ncham G; Achem E; Banin AN; Kirkpatrick AR; Porcella SF; Agyingi LA; Meli J; Colizzi V; Nádas A; Gorny MK; Nyambi PN; Quinn TC; Duerr R
    J Clin Microbiol; 2017 Sep; 55(9):2785-2800. PubMed ID: 28659324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Roche prototype 454 HIV-1 ultradeep sequencing drug resistance assay in a routine diagnostic laboratory.
    Garcia-Diaz A; Guerrero-Ramos A; McCormick AL; Macartney M; Conibear T; Johnson MA; Haque T; Webster DP
    J Clin Virol; 2013 Oct; 58(2):468-73. PubMed ID: 23954217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promises and pitfalls of Illumina sequencing for HIV resistance genotyping.
    Brumme CJ; Poon AFY
    Virus Res; 2017 Jul; 239():97-105. PubMed ID: 27993623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep sequencing for HIV-1 clinical management.
    Casadellà M; Paredes R
    Virus Res; 2017 Jul; 239():69-81. PubMed ID: 27818211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MinVar: A rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencing.
    Huber M; Metzner KJ; Geissberger FD; Shah C; Leemann C; Klimkait T; Böni J; Trkola A; Zagordi O
    J Virol Methods; 2017 Feb; 240():7-13. PubMed ID: 27867045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited Marginal Utility of Deep Sequencing for HIV Drug Resistance Testing in the Age of Integrase Inhibitors.
    Dalmat RR; Makhsous N; Pepper GG; Magaret A; Jerome KR; Wald A; Greninger AL
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30305383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding Domain.
    Keys JR; Zhou S; Anderson JA; Eron JJ; Rackoff LA; Jabara C; Swanstrom R
    AIDS Res Hum Retroviruses; 2015 Jun; 31(6):658-68. PubMed ID: 25748056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of amplification refractory mutation system PCR assay as a simple and effective tool to detect HIV-1 drug resistance mutations.
    Nanfack AJ; Agyingi L; Noubiap JJ; Ngai JN; Colizzi V; Nyambi PN
    J Clin Microbiol; 2015 May; 53(5):1662-71. PubMed ID: 25788547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sanger and Next Generation Sequencing Approaches to Evaluate HIV-1 Virus in Blood Compartments.
    Arias A; López P; Sánchez R; Yamamura Y; Rivera-Amill V
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30096879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep sequencing does not reveal additional transmitted mutations in patients diagnosed with HIV-1 variants with single nucleoside reverse transcriptase inhibitor resistance mutations.
    Pingen M; van der Ende ME; Wensing AM; el Barzouhi A; Simen BB; Schutten M; Boucher CA
    HIV Med; 2013 Mar; 14(3):176-81. PubMed ID: 22989004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.